Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001607062-17-000171
Filing Date
2017-04-28
Accepted
2017-04-28 16:29:51
Documents
65
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A rgbp093016form10ka2.htm 10-K/A 1212106
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7396
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 7474
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4185
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4139
  Complete submission text file 0001607062-17-000171.txt   4892914

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20160930.xml EX-101.INS 827386
7 XBRL SCHEMA FILE rgbp-20160930.xsd EX-101.SCH 52994
8 XBRL CALCULATION FILE rgbp-20160930_cal.xml EX-101.CAL 37104
9 XBRL DEFINITION FILE rgbp-20160930_def.xml EX-101.DEF 249212
10 XBRL LABEL FILE rgbp-20160930_lab.xml EX-101.LAB 229267
11 XBRL PRESENTATION FILE rgbp-20160930_pre.xml EX-101.PRE 276993
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

EIN.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 333-191725 | Film No.: 17796040
SIC: 2834 Pharmaceutical Preparations